Chapter 17
Favorite Table | Print
Autosensitization Dermatitis at a Glance
 An acute disorder triggered by infection, stasis and contact dermatitides, ionizing radiation, blunt trauma, and retained suture material.Widespread, pruritic, usually papulovesicular eruption, most frequently affecting the extremities.Related features are those of the precipitating disorder.Pathology is nondiagnostic and most often consistent with an acute spongiotic process of the epidermis with a superficial, perivascular, lymphohistiocytic infiltrate of the dermis containing occasional eosinophils.

Autosensitization dermatitis refers to a phenomenon in which an acute dermatitis develops at cutaneous sites distant from an inflammatory focus, and where the secondary acute dermatitis is not explained by the inciting cause of the primary inflammation. The classic presentation of autosensitization is that seen in patients with venous stasis disease,1 where as many as 37% of patients have been reported to develop at least one episode of autosensitization,2 and those with dermatophyte infections, where 4–5% reported having had dermatophytid reactions.3

The term autosensitization dermatitis was coined in 1921 by Whitfield to describe reaction patterns ranging from a generalized, erythematous, morbilliform, and urticarial eruption after blunt trauma to a generalized, petechial, papulovesicular dermatitis after the acute irritation of chronic stasis dermatitis.4 Subsequently, the vesicular id reactions associated with infections caused by tuberculosis,5 histoplasmosis,6 dermatophytes,7 and bacteria8 were included under this rubric.911 Noneczematous reaction patterns, including erythema multiforme12 and neutrophilic lobular panniculitis,13 have also been ascribed to autosensitization associated with various infections. Other precipitating factors for autosensitization have included the application of irritant or sensitizing chemicals,14 ionizing radiation,15,16 and retained suture material.17

Although the disease was originally thought to be due to autosensitization to epidermal antigens,11 this concept has not been experimentally verified. In murine studies designed to determine whether keratinocyte-derived proteins can serve as antigenic carriers for hapten, Fehr et al18 derived major histocompatibility complex-restricted, T-cell receptor α/β, CD4+ T-cell clones that proliferated in response to keratinocyte extracts unconjugated to hapten. In these studies, such autoreactive T-cell clones could not be derived after treatment with irritants. Nonetheless, the authors speculated that T cells autoreactive to keratinocyte antigens may be generated during the course of contact hypersensitivity and lead to the development of an id reaction.

In the most extensive study to date,1 only 4 of 81 patients with autosensitization dermatitis had serum antibodies cytotoxic to autologous or homologous skin. However, the role of such autoantibodies in mediating the disorder, even in these four patients, must be interpreted cautiously, given the high frequency of epidermal autoantibodies in the normal adult population.19

In an experiment in which guinea pigs were injected with autologous skin, Wilhelmj et al20 reported dermatitis in 2 of 11 guinea pigs, but it was not clear whether these reactions were immunologic and, if so, what the causal allergen(s) was. Other investigators using similar techniques have ...

Sign in to your MyAccess Profile while you are actively authenticated on this website via your institution (you will be able to tell by looking in the top right corner of any page – if you see your institution’s name, you are authenticated). You will then be able to access your institute’s content/subscription for 90 days from any location, after which you must repeat this process for continued access.

Ok

## Subscription Options

### AccessMedicine Full Site: One-Year Subscription

Connect to the full suite of AccessMedicine content and resources including more than 250 examination and procedural videos, patient safety modules, an extensive drug database, Q&A, Case Files, and more.